Fairfield Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Fairfield Financial Advisors's LLY Position: Q2 2026 in Review
Fairfield Financial Advisors reduced its Eli Lilly (LLY) stake by 12% in Q2 2026, selling an estimated $1.55M and leaving 11,166 shares worth $13.4M. The position accounts for 5.28% of the portfolio, ranked #4.
Fairfield Financial Advisors first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $13.6M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Fairfield Financial Advisors held 11,166 shares of Eli Lilly worth $13.4M as of Q2 2026.
- Fairfield Financial Advisors sold 1,518 Eli Lilly shares in Q2 2026, an estimated $1.55M.
- Eli Lilly made up 5.28% of Fairfield Financial Advisors's portfolio in Q2 2026, its #4 holding.
- Fairfield Financial Advisors first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
- Fairfield Financial Advisors's Eli Lilly position peaked at $13.6M in Q4 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Fairfield Financial Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.